Different immunophenotypic biomarkers associate with clinical parameters in the two ALS immune profiles.
2017-07-25T17:42:38Z (GMT) by
<p>Immune phenotypes were plotted against ALSFRS-R score or slope (ALSFRS-R points/month). XY graphs of correlations show p-value and Spearman r value. Lines represent the best fit resulting from linear regression analysis. Closed circles represent healthy volunteers, open squares represent ALS patients in Profile 1, and open diamonds represent ALS patients in Profile 2. <b>A.</b> Correlations of selected immunophenotypes to ALSFRS-R score in Profile 1 patients (top row) versus Profile 2 (bottom row). <b>B.</b> Correlations of selected immunophenotypes to slope in ALS Profile 1 patients. <b>C.</b> Survival curves of patients in each profile sub-grouped by cut-off values for PD-1<sup>+</sup> CD4<sup>+</sup> T cells. 19.7% was the cut-off value representing the median value for Profile 1 patients (Hi PD-1≥ 19.7; Lo PD-1< 19.7) and 19.5% was the cut-off value for Profile 2 patients. For CD3<sup>+</sup>CD56<sup>+</sup> T cells, 104.62 cells/μl was used as a cut-off value for Profile 2 patients and 28.21 cells/μl was used for Profile 1. <b>D.</b> CD4<sup>+</sup>CD45RA<sup>+</sup> naïve T cells show dissimilar age related associations between Profile 2 ALS patients, Profile 1 ALS patients, and healthy volunteers.</p>